Improving treatment strategies in the management of castrate-resistant prostate cancer

Maha Hussain*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Many men with prostate cancer will develop hormonal resistance. There are now multiple treatment options that have been shown to modestly improve overall survival in the metastatic castrate-resistant prostate cancer (mCRPC) setting. There are numerous other exciting agents that will likely reach the market in the next few years.

Original languageEnglish (US)
Pages (from-to)64-69
Number of pages6
JournalJournal of Managed Care Medicine
Volume17
Issue number1
StatePublished - Jan 1 2014

ASJC Scopus subject areas

  • Health Policy

Fingerprint

Dive into the research topics of 'Improving treatment strategies in the management of castrate-resistant prostate cancer'. Together they form a unique fingerprint.

Cite this